Mean Level of Protein C, Protein S and Antithrombin lll in Pediatric Nephrotic


  • Rumana Imtiaz Haematology Department, Children hospital, Lahore, Pakistan
  • Muhammad Asif Naveed Haematology Department, King Edward Medical University, Lahore, Pakistan
  • Javaria Fatima Haematology Department, Children hospital, Lahore, Pakistan
  • Saima Irum Haematology Department, Children hospital, Lahore, Pakistan
  • Shazia Yaseen Haematology Department, Children hospital, Lahore, Pakistan
  • Sarah Rafi Haematology Department, Children hospital, Lahore, Pakistan



Protein C, Protein S, Anthitrombin III, Nephrotic syndrome


The triad of clinical symptoms linked with proteinuria of nephrotic range, including hypoalbuminemia and edema, is known as nephrotic syndrome. When body excrete more than40 mg/m2/hr of protein or a first morning protein: creatinine ratio of more than 2-3: 1 then we call it proteinuria of nephrotic range.(1)It is estimated that the vast majority of children with nephrotic syndrome have some form of primary or idiopathic sickness, with minimal change disease being the most prevalent.Thromboembolic consequences are more common in people who have nephrotic syndrome. (2) This study tends to shed light if there is increase or decrease in level of protein C, S or antithrombin III in nephrotic syndrome. OBJECTIVE: To determine the mean level of protein C, protein S and AT Ill in children with nephrotic syndrome. SETTING: The research was conducted at Department of Haematology at Children Hospital Lahore. STUDY DESIGN: Cross sectional study. DURATION OF STUDY: The study was completed in six months from 25-08-2017 to 29-02-2018. DATA COLLECTION PROCEDURE: Patients fulfilling the inclusion criteria were taken for Protein C, Protein S and Antithrombin III assays Collect blood 3ml (9 vol) in 0.109M (3.2%) anticoagulant (1 Vol) and Centrifuge. All centrifuge specimens were run in DIAGNOSTIC STAGO. Results: A total of 100 children with nephrotic syndrome were enrolled after fulfilling inclusion criteria. The mean age of the children was 6.26±2.72 month. 69(69%) were male children. Protein C level was 95.31±16.02, Protein S level 84.05±13.31 and antithrombin III level was 86.50±16.36. Conclusion: Protein C, S and Antithrombin III level were within normal range. Further studies are needed to delineate the exact pathogenesis behind thromboembolic phenomenon in nephrotic syndrome children.


Singh R, Bhalla K, Nanda S, Gupta A, Mehra S. Correlation of spot urinary protein: Creatinine ratio and quantitative proteinuria in pediatric patients with nephrotic syndrome. Journal of Family Medicine and Primary Care [Internet]. 2019 [cited 2022 Jan 2];8(7):2343. Available from: /pmc/articles/PMC6691425/

Pasini A, Benetti E, Conti G, Ghio L, Lepore M, Massella L, et al. The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part i - Diagnosis and treatment of the first episode and the first relapse. Italian Journal of Pediatrics [Internet]. 2017 Apr 21 [cited 2022 Jan 2];43(1):1–15. Available from:

Lin R, McDonald G, Jolly T, Batten A, Chacko B. A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome. Kidney International Reports. 2020 Apr 1;5(4):435–47.

Sharp W, Olivero JJ. Venous Thrombosis in Nephrotic Syndrome. Methodist DeBakey Cardiovascular Journal [Internet]. 2018 Jul 1 [cited 2022 Jan 2];14(3):237. Available from: /pmc/articles/PMC6217559/

Evaluation of hemostatic factors in children with nephrotic syndrome [Internet]. [cited 2022 Jan 2]. Available from:

Elidrissy ATH, Gader AMA. Antithrombin III (AT III) and fibrinogen levels in nephrotic syndrome in children. Haemostasis [Internet]. 1985 [cited 2022 Jan 2];15(6):384–8. Available from:

Kaufman DP, Basit H, Knohl SJ. Physiology, Glomerular Filtration Rate. StatPearls [Internet]. 2021 Jul 22 [cited 2022 Jan 3]; Available from:

Artoni A, Passamonti SM, Edefonti A, Gianniello F, Civelli V, Martinelli I. Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency. Italian Journal of Pediatrics [Internet]. 2016 Feb 29 [cited 2022 Jan 3];42(1):1–4. Available from:

Suri D, Ahluwalia J, Saxena AK, Sodhi KS, Singh P, Mittal BR, et al. Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. ClinExpNephrol. 2014 Oct 11;18(5):803–13.

el Ghannam MZ, Ali AAEM, el Samanoudy MI, Kamel AR. Assessment of The Level of Protein C in Children with Nephrotic Syndrome. The Egyptian Journal of Hospital Medicine [Internet]. 2019 Jul 1 [cited 2022 Jan 3];76(3):3828–34. Available from:

Soff GA, Sica DA, Marlar RA, Evans HJ, Qureshi GD. Protein C levels in nephrotic syndrome: use of a new enzyme-linked immunoadsorbent assay for protein C antigen. American journal of hematology [Internet]. 1986 [cited 2022 Jan 3];22(1):43–9. Available from:

Pokrajac D, Kamber AH, Karasalihovic Z. Children with Steroid-Resistant Nephrotic Syndrome: A Single -Center Experience. Materia Socio-Medica [Internet]. 2018 [cited 2022 Jan 3];30(2):84. Available from: /pmc/articles/PMC6029918/

Zaffanello M, Franchini M, Zaffanell0 M. Thromboembolism in childhood nephrotic syndrome: A rare but serious complication informa healthcare Thromboembolism in childhood nephrotic syndrome: A rare but serious complication. 2007 [cited 2022 Jan 3]; Available from:

Anand N K, Chand G, Talib V H, Chellani H, Pande J. Hemostatic profile in nephrotic syndrome. Indian Pediatrics. 1996;33(12):1005–12.

Citak A, Emre S, Şirin A, Bilge I, Nayir A. Hemostatic problems and thromboembolic complications in nephrotic children. Pediatric Nephrology. 2000;14(2):138–42.

Yermiahu T, Shalev H, Landau D, Dvilansky A. Protein C and protein S in pediatric nephrotic patients - PubMed. Sangre (Barc) [Internet]. 1996 [cited 2022 Jan 4];41(2):155–7. Available from:



DOI: 10.54393/pbmj.v5i1.214
Published: 2022-01-31

How to Cite

Imtiaz, R. ., Naveed , M. A. ., Fatima , J. ., Irum, S. ., Yaseen, S., & Rafi, S. (2022). Mean Level of Protein C, Protein S and Antithrombin lll in Pediatric Nephrotic . Pakistan BioMedical Journal, 5(1), 221–224.



Original Article